MVA Pharma
Board
2 directors, no change since July 2020Director (not named in the articles)
appointed by deed of 20-07-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 07-07-2026
Director (not named in the articles)
appointed by deed of 20-07-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 07-07-2026
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), appointed by deed of 20-07-2020, still in office
-
- Director (not named in the articles), appointed by deed of 20-07-2020, still in office
Control
Shareholders
,
This company
MVA Pharma
Equity €240,013
Profit €36,057 in 2025
Capital
- Contribution
- €7,401.46
- Source
- 2025 annual accounts
Articles of association
deed of 20-07-2020 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs proportionnellement si plusieurs, Article 14”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Wednesday of June at 17:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
Contribution
deed of 20-07-2020 ↗
- 250 shares
Stated in the deed
deed of 20-07-2020 ↗
- 125 shares
- 125 shares